Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 2954-2956, July 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Felix, C. A.
Right arrow Articles by Lange, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Felix, C. A.
Right arrow Articles by Lange, B. J.

Common Region of ALL-1 Gene Disrupted in Epipodophyllotoxin-related Secondary Acute Myeloid Leukemia

Carolyn A. Felix1, Naomi J. Winick, Massimo Negrini, W. Paul Bowman, Carlo M. Croce and Beverly J. Lange

Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 [C. A. F., B. J. L.]; Center for Cancer and Blood Disorders, Children's Medical Center of Dallas, University of Texas Southwestern Medical Center, Dallas, Texas 75235 [N. J. W.]; Thomas Jefferson University Cancer Research Center, Philadelphia, Pennsylvania 19107 [M. N., C. M. C.]; and Department of Pediatrics, Cook-Fort Worth Children's Medical Center, Fort Worth, Texas 76104 [W. P. B.]

Translocations at chromosomal band 11q23 characterize most de novo acute lymphoblastic leukemias (ALL) of infants, acute myeloid leukemias (AML) of infants and young children, and secondary AMLs following epipodophyllotoxin exposure. The chromosomal breakpoints at 11q23 have been cloned from isolated cases of de novo ALL and AML. Using an 859-base pair BamHI fragment of human ALL-1 complementary DNA that recognizes the genomic breakpoint region for de novo ALL and AML, we investigated two cases of secondary AML that followed etoposidetreated primary B-lineage ALL. In the first case, the translocation occurred between chromosomes 9 and 11 and the breakpoint at 11q23 localized to the same 9-kilobase region of the ALL-1 gene that is disrupted in most of the de novo leukemias. In the second case the translocation was between chromosomes 11 and 19. The breakpoint occurred outside of the ALL-1 breakpoint cluster region.

1 To whom requests for reprints should be addressed, at Division of Oncology, Department of Pediatrics, Room 9093, Children's Hospital of Philadelphia, 34th St. and Civic Center Blvd., Philadelphia, PA 19104.

Received 4/12/93. Accepted 5/12/93.




This article has been cited by other articles:


Home page
Cancer Res.Home page
C. J. Betti, M. J. Villalobos, M. O. Diaz, and A. T. M. Vaughan
Apoptotic Stimuli Initiate MLL-AF9 Translocations that Are Transcribed in Cells Capable of Division
Cancer Res., March 15, 2003; 63(6): 1377 - 1381.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. Felix, A. H. Walker, B. J. Lange, T. M. Williams, N. J. Winick, N.-K. V. Cheung, B. D. Lovett, P. C. Nowell, I. A. Blair, and T. R. Rebbeck
Association of CYP3A4 genotype with treatment-related leukemia
PNAS, October 27, 1998; 95(22): 13176 - 13181.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. K. Slany, C. Lavau, and M. L. Cleary
The Oncogenic Capacity of HRX-ENL Requires the Transcriptional Transactivation Activity of ENL and the DNA Binding Motifs of HRX
Mol. Cell. Biol., January 1, 1998; 18(1): 122 - 129.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. D. Megonigal, E. F. Rappaport, D. H. Jones, C. S. Kim, P. C. Nowell, B. J. Lange, and C. A. Felix
Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias
PNAS, October 14, 1997; 94(21): 11583 - 11588.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. D. Rowley, S. Reshmi, O. Sobulo, T. Musvee, J. Anastasi, S. Raimondi, N. R. Schneider, J. C. Barredo, E. S. Cantu, B. Schlegelberger, et al.
All Patients With the T(11; 16)(q23; p13.3) That Involves MLL and CBP Have Treatment-Related Hematologic Disorders
Blood, July 15, 1997; 90(2): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. D. Rowley, C. Vignon, S. M. Gollin, C. L. Rosenberg, H. E. Wyandt, and A. Milunsky
Chromosomal Translocations in Secondary Acute Myeloid Leukemia
N. Engl. J. Med., February 29, 1996; 334(9): 601 - 603.
[Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Caslini, A. Shilatifard, L. Yang, and J. L. Hess
The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation
PNAS, March 14, 2000; 97(6): 2797 - 2802.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.